News | July 30, 2024
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
A significant proportion of healthcare professionals still tend to favor branded drugs
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
These approvals mark significant progress for Venus Remedies in expanding its market presence
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Subscribe To Our Newsletter & Stay Updated
